Ethological and 6-[F-18]fluoro-L-DOPA-PET profiles of long-term vulnerability to chronic amphetamine

被引:18
作者
Melega, WP
Raleigh, MJ
Stout, DB
Huang, SC
Phelps, ME
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT PSYCHIAT,LOS ANGELES,CA 90095
[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT RADIOL,LOS ANGELES,CA 90095
[3] UNIV CALIF LOS ANGELES,SCH MED,BRAIN RES INST,LOS ANGELES,CA 90095
[4] VET ADM MED CTR,SEPULVEDA,CA 91343
关键词
positron emission tomography; fluoro-L-DOPA; monkey; dopamine; amphetamine; behavior; neurotoxicity;
D O I
10.1016/S0166-4328(97)83333-5
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
A chronic 10-day amphetamine (Amp) protocol was used to induce significant long-term decrements of the striatal [F-18]fluoro-L-DOPA influx rate constant (FDOPA K-i) in the vervet monkey. Longitudinal FDOPA-positron emission tomography (PET) assessment in Amp-treated subjects subsequently revealed a gradual recovery of striatal dopamine function: FDOPA K-i values were decreased by similar to 70% at 1 month, similar to 45% at 6 months, similar to 20% at 12 months and were similar to pre-Amp values at 24 months. Motoric and social behavioral measures were obtained on all subjects within a species-typical group setting. Behavioral observations were conducted during both basal and stressor-challenge conditions, the latter being created by placing a potential intruder-animal in an individual cage adjacent to the subject's group enclosure. During basal conditions, post-Amp stereotypies were present at 2 weeks and locomotor behaviors were increased throughout 1 month; both alterations occurred while FDOPA K-i values were significantly decreased. Social behaviors were also significantly affected; affiliative behavior was decreased up to 6 months while aggressive behavior was increased for 12 months. However, a different pattern of behavioral changes emerged under stressor-challenge conditions. Motoric and social changes were of greater magnitude and persisted longer than in basal settings while aggressive behavior remained elevated at 24 months. These results indicate that chronic Amp-induced decreases in FDOPA K-i values and behavioral alterations are reversible. Changes in striatal dopamine function as indexed with FDOPA-PET are not correlated with post-Amp alterations in behaviors and moreover, expression of those behaviors is context-dependent.
引用
收藏
页码:259 / 268
页数:10
相关论文
共 44 条
  • [21] 6-[18F]Fluoro-L-DOPA Uptake in the Rat Pancreas is Dependent on the Tracer Metabolism
    Kalliokoski, Teemu
    Tuomela, Johanna
    Haavisto, Laura
    Forsback, Sarita
    Snellman, Anniina
    Helin, Semi
    Gronroos, Tove J.
    Solin, Olof
    Haaparanta-Solin, Merja
    MOLECULAR IMAGING AND BIOLOGY, 2014, 16 (03) : 403 - 411
  • [22] A Dual-Tracer Study of Extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa Uptake in Parkinson's Disease
    Li, Clarence T.
    Palotti, Matthew
    Holden, James E.
    Oh, Jen
    Okonkwo, Ozioma
    Christian, Bradley T.
    Bendlin, Barbara B.
    Buyan-Dent, Laura
    Harding, Sandra J.
    Stone, Charles K.
    DeJesus, Onofre T.
    Nickles, Robert J.
    Gallagher, Catherine L.
    SYNAPSE, 2014, 68 (08) : 325 - 331
  • [23] Effect of hypoxia/hypercapnia on metabolism of 6-[18F]fluoro-L-DOPA in newborn piglets
    Bauer, R
    Brust, P
    Walter, B
    Vorwieger, G
    Bergmann, R
    Elhalag, E
    Fritz, A
    Steinbach, J
    Füchtner, F
    Hinz, R
    Zwiener, U
    Johannsen, B
    BRAIN RESEARCH, 2002, 934 (01) : 23 - 33
  • [24] Enantioselective synthesis of no-carrier added (NCA) 6-[18F]Fluoro-L-Dopa
    Duanzhi Yin
    Lan Zhang
    Ganghua Tang
    Xiaolan Tang
    Yongxian Wang
    Journal of Radioanalytical and Nuclear Chemistry, 2003, 257 : 179 - 185
  • [25] Pancreatic uptake and radiation dosimetry of 6-[18F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism
    Garg, Pradeep K.
    Lokitz, Stephen J.
    Truong, Lisa
    Putegnat, Burton
    Reynolds, Courtney
    Rodriguez, Larry
    Nazih, Rachid
    Nedrelow, Jonathan
    de la Guardia, Miguel
    Uffman, John K.
    Garg, Sudha
    Thornton, Paul S.
    PLOS ONE, 2017, 12 (11):
  • [26] Evaluation of two nucleophilic syntheses routes for the automated synthesis of 6-[18F]fluoro-L-DOPA
    Pretze, Marc
    Franck, Dominic
    Kunkel, Falk
    Fosshag, Erich
    Waengler, Carmen
    Waengler, Bjoern
    NUCLEAR MEDICINE AND BIOLOGY, 2017, 45 : 35 - 42
  • [27] HUMAN STRIATAL L-DOPA DECARBOXYLASE ACTIVITY ESTIMATED INVIVO USING 6-[F-18]FLUORO-DOPA AND POSITRON EMISSION TOMOGRAPHY - ERROR ANALYSIS AND APPLICATION TO NORMAL SUBJECTS
    KUWABARA, H
    CUMMING, P
    REITH, J
    LEGER, G
    DIKSIC, M
    EVANS, AC
    GJEDDE, A
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (01) : 43 - 56
  • [28] METABOLISM AND BLOOD-BRAIN CLEARANCE OF L-3,4-DIHYDROXY-[H-3]PHENYLALANINE ([H-3]DOPA) AND 6-[F-18]FLUORO-L-DOPA IN THE RAT
    CUMMING, P
    ASE, A
    DIKSIC, M
    HARRISON, J
    JOLLY, D
    KUWABARA, H
    LALIBERTE, C
    GJEDDE, A
    BIOCHEMICAL PHARMACOLOGY, 1995, 50 (07) : 943 - 946
  • [29] The effects of carbidopa on uptake of 6-18F-fluoro-L-DOPA in PET of pheochromocytorna and extraadrenal abdominal paraganglioma
    Timmers, Henri J. L. M.
    Hadi, Mohiuddin
    Carrasquillo, Jorge A.
    Chen, Clara C.
    Martiniova, Lucia
    Whatley, Millie
    Ling, Alexander
    Eisenhofer, Graeme
    Adams, Karen T.
    Pacak, Karel
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (10) : 1599 - 1606
  • [30] DISTRIBUTION AND KINETICS OF 3-O-METHYL-6-[F-18]FLUORO-L-DOPA IN THE RHESUS-MONKEY BRAIN
    DOUDET, DJ
    MCLELLAN, CA
    CARSON, R
    ADAMS, HR
    MIYAKE, H
    AIGNER, TG
    FINN, RT
    COHEN, RM
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1991, 11 (05) : 726 - 734